Echo IQ has secured firm commitments to raise approximately $110 million through an institutional share placement. The placement shares are priced at $1.45 each, representing an 8.8% discount to the ...

The Australian Competition and Consumer Commission has blocked Coles from acquiring a leasehold interest for a new supermarket and liquor site in Kalgoorlie-Boulder. The regulatory block prevents the ...

Symal Group has agreed to acquire 100% of Queensland-based civil contractor Shamrock Civil for an upfront payment of $51 million. The transaction includes $40.8 million in cash and $10.2 million in ...

Salesforce (NYSE:CRM) has entered a definitive agreement to acquire Fin, an AI customer agent company, for approximately $3.6 billion. The acquisition aims to expand Salesforce’s Agentforce platform, ...

IREN has finalized the buyout of Ingenostrum, S.L. (Nostrum Group), establishing its first operational footprint in Europe. The transaction absorbs 490MW of secured, grid-connected power capacity in ...

Oracle (NYSE:ORCL) reported record fourth-quarter and full-year 2026 financial results, with broad-based growth across its Cloud Infrastructure and Cloud Applications businesses. Total Q4 revenues ...

A Los Angeles County Superior Court jury has ordered Johnson & Johnson (NYSE:JNJ) to pay $32 million to the family of a California woman who died from pleural mesothelioma, concluding that her fatal ...

APA Corporation (NASDAQ:APA) announced an agreement to acquire Savant Alaska for approximately $70 million in upfront cash, moving to lock down strategic midstream and field infrastructure on Alaska's ...

Tianqi Lithium and IGO (ASX:IGO) are locked in a high-stakes standoff with the Australian Taxation Office, facing a potential financial exposure exceeding $170 million plus hefty penalties. Filings ...

Alphabet's Google (NASDAQ:GOOGL) has placed an order with Intel (NASDAQ:INTC) to manufacture more than 3 million of its custom artificial intelligence processors in 2028, according to a report from ...

AstraZeneca (NASDAQ:AZN) unveiled positive data from its late-stage EMERALD-3 clinical trial on Monday, demonstrating that adding its dual-immunotherapy regimen to standard localized therapy ...

The CFTC has approved Kalshi’s request to offer perpetual futures in the US, beginning with contracts linked to Bitcoin’s price. The order marks another step in the regulator’s wider acceptance of ...